Organon & Co
723 hedge funds and large institutions have $3.81B invested in Organon & Co in 2024 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 214 increasing their positions, 253 reducing their positions, and 80 closing their positions.
59% more call options, than puts
Call options by funds: $36M | Put options by funds: $22.7M
13% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 80
0.22% more ownership
Funds ownership: 77.17% → 77.39% (+0.22%)
0% more funds holding
Funds holding: 723 → 723 (0)
7% less capital invested
Capital invested by funds: $4.11B → $3.81B (-$298M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
15% less repeat investments, than reductions
Existing positions increased: 214 | Existing positions reduced: 253
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$35.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24.1M |
| 3 |
DRZID
DePrince Race & Zollo Inc (DRZ)
Winter Park,
Florida
|
+$20.7M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$19.4M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Slate Path Capital
New York
|
-$60.7M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$31.4M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$20.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$15.8M |
OGN Hedge Fund Activity: Q3 2024 in Review
723 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q3 2024, worth a combined $3.81B — down 7.3% from $4.11B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new OGN positions and 80 closed out — a net gain of 10 holders — while 214 added to existing stakes and 253 trimmed.
The largest buyer was Weiss Asset Management, opening a new position worth an estimated $35.7M. The largest seller was Slate Path Capital, cutting an estimated $60.7M.
- 723 institutional investors held Organon & Co (OGN) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $3.81B of Organon & Co stock for Q3 2024, down 7.3% quarter-over-quarter.
- 90 funds opened new Organon & Co positions in Q3 2024 and 80 closed out, a net change of +10 holders.
- The largest Organon & Co buyer in Q3 2024 was Weiss Asset Management, an estimated $35.7M added.
- The largest Organon & Co seller in Q3 2024 was Slate Path Capital, an estimated $60.7M sold.
Based on aggregated 13F filings for Q3 2024.